stockrow
Friday 6 November 2026
Export USPH’s income statement to Excel — free account
U.S. Physical Therapy, Inc.
USPH Healthcare Medical Care Facilities
U.S. Physical Therapy, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $781.0 million, up 16.3% from fiscal 2024.
- Revenue
- +12.9%
- EPS
- −316.7%
- Free cash flow
- +32.2%
- Total debt
- +59.6%
Quarter to September 2026, against a year earlier
99.88
2.68
+2.76%
Follow USPH
Alert me
| Sep '26 From the 10-Q filed 5 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
| 0.00% | 4.34% | 5.30% | 8.19% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
— | 6 | 6 | 7 | |
| 0.00% | 1.70% | 2.12% | 3.34% | ||
ROIC |
0.00% | 7.48% | 7.83% | 9.12% | |
Return on Tangible Assets |
0.00% | 29.44% | 42.49% | 108.15% | |
Average Days of Receivables |
42.44 | 44.11 | 44.38 | 41.28 | |
Free Cash Flow per Share |
4.63 | 4.25 | 4.40 | 4.02 | |
Free Cash Flow |
69.10 | 64.07 | 66.68 | 60.99 | |
Capital Expenditures |
(19.74) | (18.98) | (16.86) | (14.07) | |
| Other line items | |||||
Cash ROIC |
9.73% | 9.29% | 9.64% | 9.17% | |
Accounts Receivable Turnover |
8.88 | 8.48 | 8.48 | 8.98 | |
Accounts Payable Turnover |
106.41 | 118.83 | 100.28 | 105.26 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
2.88 | 3.82 | 3.83 | 3.50 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.25) | (0.26) | (0.26) | (0.25) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
8.74% | 8.97% | 8.96% | 8.87% | |
Share Based Compensation of Revenue |
1.26% | 1.21% | 1.11% | 1.06% | |
Interest Coverage |
— | 7.11 | 7.97 | 9.16 | |
Operating CF/Net income |
0.00 | 4.02 | 3.25 | 1.90 | |
Depreciation/Fixed assets |
0.00 | 0.56 | 0.59 | 0.64 | |
Capex/Depreciation |
0.00 | (0.83) | (0.73) | (0.62) | |
Revenue per Share |
56.11 | 53.90 | 52.45 | 51.47 | |
Operating CF per Share |
5.95 | 5.51 | 5.51 | 4.95 | |
Capex per Share |
(1.32) | (1.26) | (1.11) | (0.93) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates · fundamentals updated 5 Nov 2026